SEARCH

SEARCH BY CITATION

References

  • Alfonso I, Hahn JS, Papazian O, Martinez YL, Reyes MA & Aicardi J (1997). Bilateral tonic-clonic epileptic seizures in non-benign familial neonatal convulsions. Pediatr Neurol 16, 249251.
  • Bassi MT, Balottin U, Panzeri C, Piccinelli P, Castaldo P, Barrese V, Soldovieri MV, Miceli F, Colombo M, Bresolin N, Borgatti R & Taglialatela M (2005). Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC). Neurogenetics 6, 185193.
  • Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ & Steinlein OK (1998). A potassium channel mutation in neonatal human epilepsy. Science 279, 403406.
  • Borgatti R, Zucca C, Cavallini A, Ferrario M, Panzeri C, Castaldo P, Soldovieri MV, Baschirotto C, Bresolin N, Dalla Bernardina B, Taglialatela M & Bassi MT (2004). A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology 63, 5765.
  • Brown DA & Adams PR (1980). Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 283, 673676.
  • Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P & Litt M (1994). Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8, 136140.
  • Castaldo P, Del Giudice EM, Coppola G, Pascotto A, Annunziato L & Taglialatela M (2002). Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J Neurosci 22, RC199.
  • Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ & Leppert M (1998). A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18, 5355.
  • Chouabe C, Neyroud N, Gulcheney P, Lazdunski M, Romey G & Barhanin J (1997). Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J 16, 54725479.
  • Cooper EC, Aldape KD, Abosch A, Barbaro NM, Berger MS, Peacock WS, Jan YN & Jan LY (2000). Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc Natl Acad Sci U S A 97, 49144919.
  • Coppola G, Castaldo P, Miraglia Del Giudice E, Bellini G, Galasso F, Soldovieri MV, Anzalone L, Sferro C, Annunziato L, Pascotto A & Taglialatela M (2003). A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology 61, 131134.
  • Dedek K, Fusco L, Teloy N & Steinlein OK (2003). Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res 54, 2127.
  • Dedek K, Kunath B, Kananura C, Reuner U, Jentsch TJ & Steinlein OK (2001). Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci U S A 98, 1227212277.
  • Delmas P & Brown DA (2005). Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6, 850862.
  • Devaux JJ, Kleopa KA, Cooper EC & Scherer SS (2004). KCNQ2 is a nodal K+ channel. J Neurosci 24, 12361244.
  • Dupuis DS, Schroder RL, Jespersen T, Christensen JK, Christophersen P, Jensen BS & Olesen SP (2002). Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. Eur J Pharmacol 437, 129137.
  • Etxeberria A, Aivar P, Rodriguez-Alfaro JA, Alaimo A, Villace P, Gomez-Posada JC, Areso P & Villarroel A (2007). Calmodulin regulates the trafficking of KCNQ2 potassium channels. Faseb J doi: DOI: 10.1096/fj.07-9712com.
  • Geiger J, Weber YG, Landwehrmeyer B, Sommer C & Lerche H (2006). Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain. Neurosci Lett 400, 101104.
  • Golomb D, Yue C & Yaari Y (2006). Contribution of persistent Na+ current and M-type K+ current to somatic bursting in CA1 pyramidal cells: combined experimental and modeling study. J Neurophysiol 96, 19121926.
  • Hadley JK, Passmore GM, Tatulian L, Al-Qatari M, Ye F, Wickenden AD & Brown DA (2003). Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium. J Neurosci 23, 50125019.
  • Hart IK, Maddison P, Newsom-Davis J, Vincent A & Mills KR (2002). Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125, 18871895.
  • Heron SE, Cox K, Grinton BE, Zuberi SM, Kivity S, Afawi Z, Straussberg R, Berkovic SF, Scheffer IE & Mulley JC (2007). Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet 44, 791796.
  • Hirose S, Zenri F, Akiyoshi H, Fukuma G, Iwata H, Inoue T, Yonetani M, Tsutsumi M, Muranaka H, Kurokawa T, Hanai T, Wada K, Kaneko S & Mitsudome A (2000). A novel mutation of KCNQ3 (c.925T→C) in a Japanese family with benign familial neonatal convulsions. Ann Neurol 47, 822826.
  • Howard RJ, Clark KA, Holton JM & Minor DL Jr (2007). Structural insight into KCNQ (Kv7) channel assembly and channelopathy. Neuron 53, 663675.
  • Hunter J, Maljevic S, Shankar A, Siegel A, Weissman B, Holt P, Olson L, Lerche H & Escayg A (2006). Subthreshold changes of voltage-dependent activation of the KV7.2 channel in neonatal epilepsy. Neurobiol Dis 24, 194201.
  • Jentsch TJ (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1, 2130.
  • Jiang Y, Lee A, Chen J, Cadene M, Chait BT & MacKinnon R (2002). The open pore conformation of potassium channels. Nature 417, 523526.
  • Kubisch C, Schroeder BC, Friedrich T, Lütjohann B, El-Amraoui A, Martin S, Petit C & Jentsch TJ (1999). KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437446.
  • Lerche H, Biervert C, Alekov AK, Schleithoff L, Lindner M, Klinger W, Bretschneider F, Mitrovic N, Jurkat-Rott K, Bode H, Lehmann-Horn F & Steinlein OK (1999). A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 46, 305312.
  • Lerche H, Weber YG, Jurkat-Rott K & Lehmann-Horn F (2005). Ion channel defects in idiopathic epilepsies. Curr Pharm Des 11, 27372752.
  • Long SB, Campbell EB & Mackinnon R (2005). Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309, 897903.
  • Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ & Burbidge SA (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58, 253262.
  • Maljevic S, Kempfle J, Weber YG, Blazevic D & Lerche H (2007). Developmental expression of KCNQ2 and KCNQ3 potassium channels at the axon initial segments of the mouse brain. Abstr Soc Neurosci, San Diego .
  • Maljevic S, Lerche C, Seebohm G, Alekov AK, Busch AE & Lerche H (2003). C-terminal interaction of KCNQ2 and KCNQ3 K+ channels. J Physiol 548, 353360.
  • Miraglia Del Giudice E, Coppola G, Scuccimarra G, Cirillo G, Bellini G & Pascotto A (2000). Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor. Eur J Hum Genet 8, 994997.
  • Neubauer B, Waldegger S, Hahn A, Eberhardt F, Kurlemann G, Garkisch S, Müller U, Stephani U & Sander T (2007). KCNQ3 and KCNQ2 mutations contribute to rare and common forms of idiopathic epilepsy. Epilepsia 48, 166.
  • Okada M, Zhu G, Hirose S, Ito KI, Murakami T, Wakui M & Kaneko S (2003). Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res 53, 8194.
  • Otto JF, Kimball MM & Wilcox KS (2002). Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol Pharmacol 61, 921927.
  • Pan Z, Kao T, Horvath Z, Lemos J, Sul JY, Cranstoun SD, Bennett V, Scherer SS & Cooper EC (2006). A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci 26, 25992613.
  • Richards MC, Heron SE, Spendlove HE, Scheffer IE, Grinton B, Berkovic SF, Mulley JC & Davy A (2004). Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2–calmodulin interaction. J Med Genet 41, e35.
  • Rundfeldt C & Netzer R (2000). The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci Lett 282, 7376.
  • Schenzer A, Friedrich T, Pusch M, Saftig P, Jentsch TJ, Grotzinger J & Schwake M (2005). Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci 25, 50515060.
  • Schmitt N, Schwarz M, Peretz A, Abitbol I, Attali B & Pongs O (2000). A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J 19, 332340.
  • Schmitt B, Wohlrab G, Sander T, Steinlein OK & Hajnal BL (2005). Neonatal seizures with tonic clonic sequences and poor developmental outcome. Epilepsy Res 65, 161168.
  • Schroeder BC, Kubisch C, Stein V & Jentsch TJ (1998). Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 396, 687690.
  • Schwake M, Jentsch TJ & Friedrich T (2003). A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. EMBO Rep 4, 7681.
  • Schwake M, Pusch M, Kharkovets T & Jentsch TJ (2000). Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy. J Biol Chem 275, 1334313348.
  • Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV, McHarg ML, Gagnon D, Rosales TO, Peiffer A, Anderson VE & Leppert M (1998). A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18, 2529.
  • Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, Anderson VE, Sanguinetti MC & Leppert MF (2003). KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 126, 27262737.
  • Smith JS, Iannotti CA, Dargis P, Christian EP & Aiyar J (2001). Differential expression of kcnq2 splice variants: implications to m current function during neuronal development. J Neurosci 21, 10961103.
  • Soldovieri MV, Castaldo P, Iodice L, Miceli F, Barrese V, Bellini G, Miraglia Del Giudice E, Pascotto A, Bonatti S, Annunziato L & Taglialatela M (2006). Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions. J Biol Chem 281, 418428.
  • Soldovieri MV, Cilio MR, Miceli F, Bellini G, Miraglia Del Giudice E, Castaldo P, Hernandez CC, Shapiro MS, Pascotto A, Annunziato L & Taglialatela M (2007). Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J Neurosci 27, 49194928.
  • Steinlein OK, Conrad C & Weidner B (2007). Benign familial neonatal convulsions: always benign? Epilepsy Res 73, 245249.
  • Tatulian L, Delmas P, Abogadie FC & Brown DA (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21, 55355545.
  • Tinel N, Lauritzen I, Chouabe C, Lazdunski M & Borsotto M (1998). The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3. FEBS Lett 438, 171176.
  • Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, Dixon JE & McKinnon D (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282, 18901893.
  • Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, De Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD & Keating MT (1996). Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12, 1723.
  • Weber YG, Geiger J, Kampchen K, Landwehrmeyer B, Sommer C & Lerche H (2006). Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain. Brain Res 1077, 16.
  • Wehling C, Beimgraben C, Gelhaus C, Friedrich T, Saftig P, Grotzinger J & Schwake M (2007). Self-assembly of the isolated KCNQ2 subunit interaction domain. FEBS Lett 581, 15941598.
  • Wickenden AD, Yu W, Zou A, Jegla T & Wagoner PK (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 58, 591600.
  • Wollnik B, Schroeder BC, Kubisch C, Esperer HD, Wieacker P & Jentsch TJ (1997). Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Gen 6, 19431949.
  • Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F & Lerche H (2007). Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology 69, 20452053.
  • Wuttke TV & Lerche H (2006). Novel anticonvulsant drugs targeting voltage-dependent ion channels. Expert Opin Invest Drugs 15, 11671177.
  • Wuttke TV, Penzien J, Fauler M, Seebohm G, Lehmann-Horn F, Lerche H & Jurkat-Rott K (2008). Neutralization of a negative charge in the S1–S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy. J Physiol 586, 545555.
  • Wuttke TV, Seebohm G, Bail S, Maljevic S & Lerche H (2005). The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 67, 10091017.
  • Yang WP, Levesque PC, Little WA, Conder ML, Ramakrishnan P, Neubauer MG & Blanar MA (1998). Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J Biol Chem 273, 1941919423.